DiaMedica Therapeutics(DMAC) - 2025 Q4 - Earnings Call Transcript

DiaMedica Therapeutics (NasdaqCM:DMAC) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsDietrich John Pauls - President and CEOJosh Schimmer - Managing DirectorJulie Krop - Chief Medical OfficerMatthew Caufield - VP of Equity ResearchMitchel Morgan - Manager of Clinical SuppliesScott Kellen - CFOStacy Ku - Biotechnology Equity ResearchConference Call ParticipantsChase Knickerbocker - Senior Research AnalystThomas Flaten - Senior Research AnalystOperatorMorning, ladies and gentlemen, and ...